Ute Wastl is an experienced professional in the pharmaceutical and biotechnology industries, currently serving as a Key-Account-Managerin Rare Disease at Ipsen since September 2024. Wastl's career includes significant roles such as Regionaler Account-Manager at Microbiotica GmbH from July 2022 to August 2024, Account Manager for Biosimilars at Biogen between October 2017 and August 2021, and Hospital Account Manager for Cardiovascular at Bristol-Myers Squibb from October 2013 to September 2017. Additional experience includes serving as an Area Sales Manager DACH at Envigo ++++ from September 2021 to January 2022 and as a Sales Representative at Pfizer from April 1998 to December 2008. Wastl holds a Doctorate (Ph.D.) in Biology from Universität Wien, awarded between 1991 and 1997, and a Master of Science in Zoology from the same institution, completed in 1991.
This person is not in the org chart
This person is not in any teams
This person is not in any offices